Literature DB >> 16891517

Comparison of the LCx human immunodeficiency virus (HIV) RNA quantitative, RealTime HIV, and COBAS AmpliPrep-COBAS TaqMan assays for quantitation of HIV type 1 RNA in plasma.

Vincent Foulongne1, Brigitte Montes, Marie-Noelle Didelot-Rousseau, Michel Segondy.   

Abstract

The LCx human immunodeficiency virus (HIV) RNA Quantitative, RealTime HIV, and COBAS AmpliPrep-COBAS TaqMan assays for HIV type 1 (HIV-1) were compared for their abilities to quantitate HIV-1 RNA in plasma. High degrees of correlation and agreement were observed between the assays. Differences in HIV-1 RNA levels according to HIV-1 subtypes did not reach statistical significance.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16891517      PMCID： PMC1594638          DOI： 10.1128/JCM.00341-06

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  17 in total

1.  Comparative analysis of HIV-1 viral load assays on subtype quantification: Bayer Versant HIV-1 RNA 3.0 versus Roche Amplicor HIV-1 Monitor version 1.5.

Authors:  Tarek Elbeik; W Gregory Alvord; Rapee Trichavaroj; Mark de Souza; Robin Dewar; Arthur Brown; David Chernoff; Nelson L Michael; Patricia Nassos; Keith Hadley; Valerie L Ng
Journal:  J Acquir Immune Defic Syndr       Date:  2002-04-01       Impact factor: 3.731

2.  A new ultrasensitive assay for quantitation of HIV-1 RNA in plasma.

Authors:  J Johanson; K Abravaya; W Caminiti; D Erickson; R Flanders; G Leckie; E Marshall; C Mullen; Y Ohhashi; R Perry; J Ricci; J Salituro; A Smith; N Tang; M Vi; J Robinson
Journal:  J Virol Methods       Date:  2001-06       Impact factor: 2.014

3.  Evaluation of the Cobas AmpliPrep/Cobas Amplicor HIV-1 Monitor Ultrasensitive Test: comparison with the Cobas Amplicor HIV-1 Monitor test (manual specimen preparation).

Authors:  Annemarie Berger; Lina Scherzed; Martin Stürmer; Wolfgang Preiser; Hans W Doerr; Holger F Rabenau
Journal:  J Clin Virol       Date:  2002-12       Impact factor: 3.168

4.  Comparison of LCx with other current viral load assays for detecting and quantifying human immunodeficiency virus type 1 RNA in patients infected with the circulating recombinant form A/G (CRF02).

Authors:  Alessandra Amendola; Licia Bordi; Claudio Angeletti; Enrico Girardi; Giuseppe Ippolito; Maria R Capobianchi
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

5.  Multicenter study of the LCx HIV RNA quantitative assay--a new competitive reverse transcriptase-PCR which targets pol genomic region of HIV-1 for the measurement of type B, non-type B and group O HIV-1 RNA.

Authors:  Hugo Troonen; Howard Grey; Gerd Michel
Journal:  Clin Chem Lab Med       Date:  2002-07       Impact factor: 3.694

6.  Prevalence of human immunodeficiency virus type 1 (HIV-1) non-B subtypes in foreigners living in Madrid, Spain, and comparison of the performances of the AMPLICOR HIV-1 MONITOR version 1.0 and the new automated version 1.5.

Authors:  A Holguín; B Aracil; A Alvarez; C Barros; V Soriano
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

7.  Evaluation of the clinical sensitivity for the quantification of human immunodeficiency virus type 1 RNA in plasma: Comparison of the new COBAS TaqMan HIV-1 with three current HIV-RNA assays--LCx HIV RNA quantitative, VERSANT HIV-1 RNA 3.0 (bDNA) and COBAS AMPLICOR HIV-1 Monitor v1.5.

Authors:  Antigoni Katsoulidou; Maria Petrodaskalaki; Vana Sypsa; Eleni Papachristou; Cleo G Anastassopoulou; Panagiotis Gargalianos; Anastasia Karafoulidou; Marios Lazanas; Theodoros Kordossis; Anastasia Andoniadou; Angelos Hatzakis
Journal:  J Virol Methods       Date:  2005-09-27       Impact factor: 2.014

8.  Performance characteristics of the QUANTIPLEX HIV-1 RNA 3.0 assay for detection and quantitation of human immunodeficiency virus type 1 RNA in plasma.

Authors:  A Erice; D Brambilla; J Bremer; J B Jackson; R Kokka; B Yen-Lieberman; R W Coombs
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

9.  Evaluation of automated sample preparation and quantitative PCR LCx assay for determination of human immunodeficiency virus type 1 RNA.

Authors:  Zsofia Muller; Evelyn Stelzl; Michael Bozic; Josef Haas; Egon Marth; Harald H Kessler
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

10.  Evaluation of the Nuclisens HIV-1 QT assay for quantitation of human immunodeficiency virus type 1 RNA levels in plasma.

Authors:  M Segondy; T D Ly; M Lapeyre; B Montes
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948
View more
  8 in total

1.  Evaluation of the Abbott investigational use only realtime HIV-1 assay and comparison to the Roche Amplicor HIV-1 monitor test, version 1.5.

Authors:  Michael T Pyne; Eric Q Konnick; Amit Phansalkar; David R Hillyard
Journal:  J Mol Diagn       Date:  2009-05-21       Impact factor: 5.568

2.  Evaluation of the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test and identification of rare polymorphisms potentially affecting assay performance.

Authors:  Michael T Pyne; Katherine L Brown; David R Hillyard
Journal:  J Clin Microbiol       Date:  2010-06-23       Impact factor: 5.948

3.  Multicenter evaluation of the new Abbott RealTime assays for quantitative detection of human immunodeficiency virus type 1 and hepatitis C virus RNA.

Authors:  M Schutten; D Peters; N K T Back; M Beld; K Beuselinck; V Foulongne; A-M Geretti; L Pandiani; C Tiemann; H G M Niesters
Journal:  J Clin Microbiol       Date:  2007-04-04       Impact factor: 5.948

4.  Comparison of the Abbott realtime human immunodeficiency virus type 1 (HIV-1) assay to the Cobas AmpliPrep/Cobas TaqMan HIV-1 test: workflow, reliability, and direct costs.

Authors:  Cari R Sloma; Jeffrey J Germer; Tara M Gerads; Jayawant N Mandrekar; P Shawn Mitchell; Joseph D C Yao
Journal:  J Clin Microbiol       Date:  2009-02-04       Impact factor: 5.948

5.  Comparative evaluation of the performance of the Abbott RealTime HIV-1 assay for measurement of HIV-1 plasma viral load on genetically diverse samples from Greece.

Authors:  Antigoni Katsoulidou; Chrysoula Rokka; Catherine Issaris; Catherine Haida; Kimon Tzannis; Vana Sypsa; Maria Detsika; Dimitrios Paraskevis; Angelos Hatzakis
Journal:  Virol J       Date:  2011-01-11       Impact factor: 4.099

6.  Cobas ampliprep/cobas TaqMan HIV-1 v2.0 assay: consequences at the cohort level.

Authors:  Ninon Taylor; Katharina Grabmeier-Pfistershammer; Alexander Egle; Richard Greil; Armin Rieger; Bruno Ledergerber; Hannes Oberkofler
Journal:  PLoS One       Date:  2013-08-30       Impact factor: 3.240

7.  Comparison of the COBAS/Ampliprep Taqman and Amplicor HIV-1 monitor tests in Lagos, Nigeria.

Authors:  Olufemi S Amoo; Idowu A Taiwo; Olumuyiwa O Salu; Azuka P Okwuraiwe; Chika K Onwuamah; Morenike A Awe; Osaga O Oforomeh; Daniel I Onwujekwe; Oliver C Ezechi; Audu R Ajuma
Journal:  Afr J Lab Med       Date:  2013-05-15

8.  Modeling the Amplification of Immunoglobulins through Machine Learning on Sequence-Specific Features.

Authors:  Matthias Döring; Christoph Kreer; Nathalie Lehnen; Florian Klein; Nico Pfeifer
Journal:  Sci Rep       Date:  2019-07-24       Impact factor: 4.379
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.